CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 40 enrolled
Drug / intervention
positive-pressure ventilation +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000572
NCT00000572Phase 3Completed
CompareCT.gov

Extracorporeal Carbon Dioxide Removal for Acute Respiratory Distress Syndrome

Intermountain Health Care, Inc.·interventional·Posted Oct 28, 1999·Updated Mar 6, 2018

In Brief

A Phase 3 clinical trial evaluating positive-pressure ventilation and extracorporeal membrane oxygenation (CO2 removal) for Acute Respiratory Distress Syndrome and Lung Diseases. Completed, enrolled 40 participants.

Detailed Summary

To compare conventional therapy using low frequency positive pressure ventilation with extracorporeal CO2 removal for the treatment of adult respiratory distress syndrome (ARDS).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Respiratory Distress Syndrome, Lung Diseases
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

Phase 3CompletedFinished
19871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartJun 1, 1987
Primary CompletionApr 1, 1991
Study CompletionJan 1, 1993
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 26.7 years ago

Interventions

positive-pressure ventilationprocedure

Detailed computer protocol controlled positive pressure ventilation

extracorporeal membrane oxygenation (CO2 removal)procedure

Detailed computer protocol controlled Extracorporeal CO2 Removal with reduced positive pressure ventilation